LDN Social Media
Get connected with us on social networks
Treatment of psoriasis vulgaris using low-dose naltrexone
JAAD Case Rep
18 September 2018
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143714/
Low-dose naltrexone significantly improved our patient's affected BSA from 10% to 1% over a span of 6 months, with continued remission to date. Treatment of psoriasis with low-dose naltrexone may be appealing because of its low side-effect profile, low cost, and its efficacy in patients with chronic inflammatory conditions.